Is fish oil or omega-3 worth trying?

What was actually studied

Trials tested supplements containing EPA, DHA, or combinations of the two in adults with major depression. Some used omega-3 alone and others added it to existing treatment.

This is not the same question as whether eating fish supports general health or whether an overall dietary pattern helps depression. A retail fish-oil bottle is also not automatically equivalent to a trial formulation.

What about algae oil?

People who don't eat fish often look for algae oil. That can supply EPA and DHA without fish.

The depression trials on this page studied omega-3 supplements, mostly fish oil. Algae oil is not automatically the same product. Formulations that included more EPA were the more discussed lead in this literature. Typical algae oils are heavier in DHA, so they especially shouldn't inherit that signal.

I haven't found a dedicated algal-oil trial package for major depression that would let algae inherit the small, low-certainty finding here. Flaxseed and other ALA oils convert only small amounts into EPA and DHA, so they don't inherit this evidence either.

What the evidence earns

Combining the trials, the overall result favored omega-3 by a small amount. The estimate was uncertain enough to include both a negligible effect and one that some people might notice.

The review did not find clear improvements in response, remission, or quality of life. One very small comparison with antidepressant treatment cannot establish that omega-3 works as well as medication.

Older analyses were sometimes more favorable, particularly for formulations that included more EPA. That remains a lead, not a settled rule for choosing a product or predicting who will respond.

What trying it actually means

Participation may look simple because the product is sold over the counter. It still means choosing and paying for a specific formulation, remembering to take it consistently, checking how it fits with other medicines and supplements, and deciding in advance what improvement would count.

The evidence does not establish one preferred dose, EPA-to-DHA ratio, duration, or interchangeable commercial product. A label that says “omega-3” does not show that the product matches what was studied.

What to expect

Any average benefit is probably small and may not be noticeable. There is no reliable way to identify a responder in advance.

Low certainty does not prove that omega-3 has no benefit. It means the current evidence cannot support a dependable treatment promise.

Omega-3 remains an active research area because it is biologically plausible, generally well tolerated, and inexpensive, even though current clinical evidence has not established a dependable antidepressant effect.

Keep its role proportionate

Omega-3 may be reasonable as a preference-sensitive, low-priority option when established care is already in place or clearly planned. It should not delay psychotherapy, medication, combined care, or urgent assessment when those are indicated.

Adverse-event rates looked similar to placebo, but the estimate was very uncertain. Being sold over the counter does not replace a safety review or establish that every product is suitable.